Table 5 |
|||||||||||
|
Genes sorted by SVM weight, bipolar versus control |
|||||||||||
|
Expression data only |
Demographic, clinical, and expression data |
||||||||||
|
|
|
||||||||||
|
All subjects |
All subjects |
||||||||||
|
|
|
||||||||||
|
SVM-weight |
p-value |
q-value |
ID |
GenBank |
Symbol |
SVM-weight |
p-value |
q-value |
ID |
GenBank |
Symbol |
|
|
|
||||||||||
|
-1.04E-01 |
4.47E-03 |
9.53E-02 |
205033_s_at |
DEFA1/3 |
2.00E-01 |
2.92E-18 |
4.66E-14 |
Drug use |
|||
|
-1.03E-01 |
1.78E-03 |
6.98E-02 |
218055_s_at |
WDR41 |
1.68E-01 |
7.09E-13 |
5.66E-09 |
Alcohol use |
|||
|
-9.48E-02 |
1.34E-02 |
1.46E-01 |
203231_s_at |
ATXN1 |
-9.09E-02 |
3.22E-04 |
3.62E-02 |
202203_s_at |
AMFR |
||
|
-9.06E-02 |
1.70E-02 |
1.63E-01 |
219525_at |
SLC47A1 |
-8.38E-02 |
4.47E-03 |
9.46E-02 |
205033_s_at |
DEFA1/3 |
||
|
8.92E-02 |
9.79E-03 |
1.27E-01 |
215147_at |
CUGBP2 |
-7.98E-02 |
1.34E-02 |
1.45E-01 |
203231_s_at |
ATXN1 |
||
|
-8.86E-02 |
3.22E-04 |
3.72E-02 |
202203_s_at |
AMFR |
7.67E-02 |
6.28E-05 |
1.96E-02 |
PMI |
|||
|
7.65E-02 |
2.36E-02 |
1.90E-01 |
204285_s_at |
PMAIP1 |
7.63E-02 |
9.79E-03 |
1.27E-01 |
215147_at |
CUGBP2 |
||
|
-7.61E-02 |
1.44E-03 |
6.36E-02 |
203031_s_at |
UROS |
6.58E-02 |
2.36E-02 |
1.89E-01 |
204285_s_at |
PMAIP1 |
||
|
-7.44E-02 |
6.61E-03 |
1.09E-01 |
218951_s_at |
PLCXD1 |
-6.40E-02 |
1.78E-03 |
6.88E-02 |
218055_s_at |
WDR41 |
||
|
7.17E-02 |
6.47E-03 |
1.09E-01 |
215528_at |
MGAT5 |
-6.23E-02 |
1.70E-02 |
1.62E-01 |
219525_at |
SLC47A1 |
||
|
-6.98E-02 |
1.54E-03 |
6.46E-02 |
221579_s_at |
NUDT3 |
-5.94E-02 |
1.05E-02 |
1.32E-01 |
209189_at |
FOS |
||
|
-6.67E-02 |
1.37E-09 |
2.19E-05 |
213921_at |
SST |
5.60E-02 |
6.47E-03 |
1.08E-01 |
215528_at |
MGAT5 |
||
|
-6.62E-02 |
1.05E-02 |
1.33E-01 |
209189_at |
FOS |
-5.49E-02 |
6.61E-03 |
1.08E-01 |
218951_s_at |
PLCXD1 |
||
|
-6.48E-02 |
6.72E-06 |
9.04E-03 |
221011_s_at |
LBH |
-5.46E-02 |
1.37E-09 |
7.31E-06 |
213921_at |
SST |
||
|
6.46E-02 |
4.79E-03 |
9.73E-02 |
217617_at |
PBX1 |
-5.44E-02 |
2.53E-03 |
7.69E-02 |
203528_at |
SEMA4D |
||
|
-5.98E-02 |
4.63E-03 |
9.59E-02 |
204507_s_at |
PPP3R1 |
-5.40E-02 |
1.54E-03 |
6.37E-02 |
221579_s_at |
NUDT3 |
||
|
-5.87E-02 |
1.26E-03 |
6.14E-02 |
204545_at |
PEX6 |
-5.33E-02 |
2.49E-03 |
7.69E-02 |
200976_s_at |
TAX1BP1 |
||
|
5.80E-02 |
2.72E-02 |
2.02E-01 |
217482_at |
HEMBB1000354 |
5.33E-02 |
4.79E-03 |
9.66E-02 |
217617_at |
PBX1 |
||
|
-5.67E-02 |
2.53E-03 |
7.78E-02 |
203528_at |
SEMA4D |
-5.23E-02 |
1.26E-03 |
6.05E-02 |
204545_at |
PEX6 |
||
|
5.45E-02 |
1.45E-02 |
1.52E-01 |
217055_x_at |
SLC1A2 |
5.17E-02 |
1.45E-02 |
1.52E-01 |
217055_x_at |
SLC1A2 |
||
|
|
|
||||||||||
|
Male subjects |
Male subjects |
||||||||||
|
|
|
||||||||||
|
-8.15E-02 |
2.96E-05 |
1.08E-01 |
219525_at |
SLC47A1 |
1.61E-01 |
4.55E-10 |
3.34E-06 |
Alcohol use |
|||
|
-6.62E-02 |
2.50E-03 |
3.49E-01 |
208151_x_at |
DDX17 |
1.27E-01 |
1.68E-12 |
2.47E-08 |
Drug use |
|||
|
-6.36E-02 |
1.02E-02 |
3.49E-01 |
218055_s_at |
WDR41 |
7.30E-02 |
3.77E-03 |
3.48E-01 |
PMI |
|||
|
-6.35E-02 |
2.91E-03 |
3.49E-01 |
205048_s_at |
PSPH |
-6.30E-02 |
2.96E-05 |
7.68E-02 |
219525_at |
SLC47A1 |
||
|
-6.12E-02 |
2.15E-03 |
3.49E-01 |
218948_at |
QRSL1 |
-5.73E-02 |
2.91E-03 |
3.48E-01 |
205048_s_at |
PSPH |
||
|
-5.44E-02 |
2.09E-03 |
3.49E-01 |
202203_s_at |
AMFR |
-5.47E-02 |
3.85E-03 |
3.48E-01 |
205924_at |
RAB3B |
||
|
5.33E-02 |
4.53E-03 |
3.49E-01 |
216006_at |
WIPF2 |
-5.16E-02 |
2.50E-03 |
3.48E-01 |
208151_x_at |
DDX17 |
||
|
-5.09E-02 |
3.85E-03 |
3.49E-01 |
205924_at |
RAB3B |
-5.14E-02 |
2.09E-03 |
3.48E-01 |
202203_s_at |
AMFR |
||
|
-4.90E-02 |
1.17E-02 |
3.49E-01 |
208719_s_at |
DDX17 |
-5.12E-02 |
2.15E-03 |
3.48E-01 |
218948_at |
QRSL1 |
||
|
4.79E-02 |
1.23E-02 |
3.49E-01 |
210738_s_at |
SLC4A4 |
-4.36E-02 |
1.02E-02 |
3.48E-01 |
218055_s_at |
WDR41 |
||
|
4.79E-02 |
4.39E-02 |
3.49E-01 |
202853_s_at |
RYK |
4.20E-02 |
4.53E-03 |
3.48E-01 |
216006_at |
WIPF2 |
||
|
4.76E-02 |
2.39E-02 |
3.49E-01 |
207181_s_at |
CASP7 |
-3.96E-02 |
2.06E-04 |
1.68E-01 |
Brain pH |
|||
|
-4.74E-02 |
2.04E-02 |
3.49E-01 |
204416_x_at |
APOC1 |
-3.84E-02 |
1.17E-02 |
3.48E-01 |
208719_s_at |
DDX17 |
||
|
4.53E-02 |
1.52E-03 |
3.49E-01 |
204712_at |
WIF1 |
3.76E-02 |
2.06E-02 |
3.48E-01 |
214722_at |
NOTCH2NL |
||
|
-4.51E-02 |
3.53E-03 |
3.49E-01 |
204545_at |
PEX6 |
3.75E-02 |
4.39E-02 |
3.48E-01 |
202853_s_at |
RYK |
||
|
-4.50E-02 |
6.16E-03 |
3.49E-01 |
205033_s_at |
DEFA1/3 |
3.74E-02 |
9.42E-03 |
3.48E-01 |
209291_at |
ID4 |
||
|
4.31E-02 |
2.46E-02 |
3.49E-01 |
219255_x_at |
IL17RB |
-3.67E-02 |
2.04E-02 |
3.48E-01 |
204416_x_at |
APOC1 |
||
|
-4.29E-02 |
8.23E-05 |
1.34E-01 |
213921_at |
SST |
-3.60E-02 |
3.53E-03 |
3.48E-01 |
204545_at |
PEX6 |
||
|
4.26E-02 |
3.48E-02 |
3.49E-01 |
218500_at |
C8orf55 |
3.56E-02 |
1.23E-02 |
3.48E-01 |
210738_s_at |
SLC4A4 |
||
|
-4.25E-02 |
5.38E-07 |
7.90E-03 |
202688_at |
TNFSF10 |
-3.55E-02 |
6.16E-03 |
3.48E-01 |
205033_s_at |
DEFA1/3 |
||
|
|
|
||||||||||
|
Female subjects |
Female subjects |
||||||||||
|
|
|
||||||||||
|
6.17E-02 |
3.51E-02 |
3.21E-01 |
211751_at |
PDE4DIP |
9.50E-02 |
3.19E-08 |
3.84E-04 |
Drug use |
|||
|
-5.56E-02 |
3.95E-02 |
3.21E-01 |
202688_at |
TNFSF10 |
8.85E-02 |
3.09E-04 |
3.21E-01 |
Left brain |
|||
|
-4.20E-02 |
1.30E-02 |
3.21E-01 |
201222_s_at |
RAD23B |
5.17E-02 |
3.51E-02 |
3.21E-01 |
211751_at |
PDE4DIP |
||
|
-4.19E-02 |
1.89E-02 |
3.21E-01 |
211990_at |
HLA-DPA1 |
5.01E-02 |
6.64E-06 |
4.00E-02 |
Age |
|||
|
-4.04E-02 |
1.00E-02 |
3.21E-01 |
202581_at |
HSPA1B |
-4.93E-02 |
3.95E-02 |
3.21E-01 |
202688_at |
TNFSF10 |
||
|
-3.77E-02 |
5.25E-02 |
3.21E-01 |
202203_s_at |
AMFR |
4.09E-02 |
2.66E-03 |
3.21E-01 |
Alcohol use |
|||
|
-3.74E-02 |
4.26E-02 |
3.21E-01 |
217757_at |
A2M |
-3.88E-02 |
1.30E-02 |
3.21E-01 |
201222_s_at |
RAD23B |
||
|
3.72E-02 |
5.74E-02 |
3.21E-01 |
213757_at |
EIF5A |
-3.71E-02 |
1.00E-02 |
3.21E-01 |
202581_at |
HSPA1B |
||
|
-3.70E-02 |
2.24E-03 |
3.21E-01 |
221579_s_at |
NUDT3 |
-3.50E-02 |
5.25E-02 |
3.21E-01 |
202203_s_at |
AMFR |
||
|
-3.62E-02 |
1.15E-03 |
3.21E-01 |
203416_at |
CD53 |
3.46E-02 |
5.74E-02 |
3.21E-01 |
213757_at |
EIF5A |
||
|
-3.49E-02 |
2.55E-03 |
3.21E-01 |
208691_at |
TFRC |
-3.29E-02 |
4.26E-02 |
3.21E-01 |
217757_at |
A2M |
||
|
3.36E-02 |
2.92E-03 |
3.21E-01 |
205990_s_at |
WNT5A |
-3.26E-02 |
1.15E-03 |
3.21E-01 |
203416_at |
CD53 |
||
|
-3.33E-02 |
2.68E-02 |
3.21E-01 |
202291_s_at |
MGP |
-3.25E-02 |
1.89E-02 |
3.21E-01 |
211990_at |
HLA-DPA1 |
||
|
-3.32E-02 |
2.63E-03 |
3.21E-01 |
200800_s_at |
HSPA1A/B |
-2.99E-02 |
2.68E-02 |
3.21E-01 |
202291_s_at |
MGP |
||
|
-3.30E-02 |
2.60E-02 |
3.21E-01 |
211038_s_at |
CROCCL1 |
-2.95E-02 |
2.24E-03 |
3.21E-01 |
221579_s_at |
NUDT3 |
||
|
-3.27E-02 |
4.16E-02 |
3.21E-01 |
218589_at |
P2RY5 |
-2.91E-02 |
2.63E-03 |
3.21E-01 |
200800_s_at |
HSPA1A/B |
||
|
-3.23E-02 |
6.22E-02 |
3.21E-01 |
203231_s_at |
ATXN1 |
2.89E-02 |
2.92E-03 |
3.21E-01 |
205990_s_at |
WNT5A |
||
|
-3.21E-02 |
5.41E-02 |
3.21E-01 |
218055_s_at |
WDR41 |
-2.89E-02 |
1.45E-02 |
3.21E-01 |
202746_at |
ITM2A |
||
|
-3.17E-02 |
3.12E-02 |
3.21E-01 |
210004_at |
OLR1 |
-2.79E-02 |
5.14E-02 |
3.21E-01 |
209458_x_at |
HBA1/2 |
||
|
-3.11E-02 |
1.70E-02 |
3.21E-01 |
206577_at |
VIP |
-2.75E-02 |
6.56E-02 |
3.21E-01 |
201718_s_at |
EPB41L2 |
||
|
|
|||||||||||
|
Struyf et al. BMC Genomics 2008 9:531 doi:10.1186/1471-2164-9-531 |
|||||||||||
